Works matching IS 18661947 AND DT 2022 AND VI 14 AND IP 1

Results: 63
    1
    2
    3
    4

    Evidence of neuroinflammation and immunotherapy responsiveness in individuals with down syndrome regression disorder.

    Published in:
    Journal of Neurodevelopmental Disorders, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s11689-022-09446-w
    By:
    • Santoro, Jonathan D.;
    • Partridge, Rebecca;
    • Tanna, Runi;
    • Pagarkar, Dania;
    • Khoshnood, Mellad;
    • Rehmani, Mustafa;
    • Kammeyer, Ryan M.;
    • Gombolay, Grace Y.;
    • Fisher, Kristen;
    • Conravey, Allison;
    • El-Dahr, Jane;
    • Christy, Alison L.;
    • Patel, Lina;
    • Manning, Melanie A.;
    • Van Mater, Heather;
    • Rafii, Michael S.;
    • Quinn, Eileen A.
    Publication type:
    Article
    5
    6
    7
    8

    Anxiety-like behavior and anxiolytic treatment in the Rett syndrome natural history study.

    Published in:
    Journal of Neurodevelopmental Disorders, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s11689-022-09432-2
    By:
    • Buchanan, Caroline B.;
    • Stallworth, Jennifer L.;
    • Joy, Aubin E.;
    • Dixon, Rebekah E.;
    • Scott, Alexandra E.;
    • Beisang, Arthur A.;
    • Benke, Timothy A.;
    • Glaze, Daniel G.;
    • Haas, Richard H.;
    • Heydemann, Peter T.;
    • Jones, Mary D.;
    • Lane, Jane B.;
    • Lieberman, David N.;
    • Marsh, Eric D.;
    • Neul, Jeffrey L.;
    • Peters, Sarika U.;
    • Ryther, Robin C.;
    • Skinner, Steve A.;
    • Standridge, Shannon M.;
    • Kaufmann, Walter E.
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Validation of a computational phenotype for finding patients eligible for genetic testing for pathogenic PTEN variants across three centers.

    Published in:
    Journal of Neurodevelopmental Disorders, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s11689-022-09434-0
    By:
    • Kothari, Cartik;
    • Srivastava, Siddharth;
    • Kousa, Youssef;
    • Izem, Rima;
    • Gierdalski, Marcin;
    • Kim, Dongkyu;
    • Good, Amy;
    • Dies, Kira A.;
    • Geisel, Gregory;
    • Morizono, Hiroki;
    • Gallo, Vittorio;
    • Pomeroy, Scott L.;
    • Garden, Gwenn A.;
    • Guay-Woodford, Lisa;
    • Sahin, Mustafa;
    • Avillach, Paul
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    The research landscape of tuberous sclerosis complex–associated neuropsychiatric disorders (TAND)—a comprehensive scoping review.

    Published in:
    Journal of Neurodevelopmental Disorders, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s11689-022-09423-3
    By:
    • Vanclooster, Stephanie;
    • Bissell, Stacey;
    • van Eeghen, Agnies M.;
    • Chambers, Nola;
    • De Waele, Liesbeth;
    • Byars, Anna W.;
    • Capal, Jamie K.;
    • Cukier, Sebastián;
    • Davis, Peter;
    • Flinn, Jennifer;
    • Gardner-Lubbe, Sugnet;
    • Gipson, Tanjala;
    • Heunis, Tosca-Marie;
    • Hook, Dena;
    • Kingswood, J. Christopher;
    • Krueger, Darcy A.;
    • Kumm, Aubrey J.;
    • Sahin, Mustafa;
    • Schoeters, Eva;
    • Smith, Catherine
    Publication type:
    Article
    28
    29

    A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABA<sub>A</sub>-α5 NAM (basmisanil) on intellectual disability associated with Down syndrome.

    Published in:
    Journal of Neurodevelopmental Disorders, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s11689-022-09418-0
    By:
    • Goeldner, Celia;
    • Kishnani, Priya S.;
    • Skotko, Brian G.;
    • Casero, Julian Lirio;
    • Hipp, Joerg F.;
    • Derks, Michael;
    • Hernandez, Maria-Clemencia;
    • Khwaja, Omar;
    • Lennon-Chrimes, Sian;
    • Noeldeke, Jana;
    • Pellicer, Sabine;
    • Squassante, Lisa;
    • Visootsak, Jeannie;
    • Wandel, Christoph;
    • Fontoura, Paulo;
    • d'Ardhuy, Xavier Liogier;
    • Clematis Study Group;
    • De La Torre Fornell, Rafael;
    • Glue, Paul;
    • Hoover-Fong, Julie
    Publication type:
    Article
    30
    31
    32
    33

    Down-regulation of the brain-specific cell-adhesion molecule contactin-3 in tuberous sclerosis complex during the early postnatal period.

    Published in:
    Journal of Neurodevelopmental Disorders, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s11689-022-09416-2
    By:
    • Korotkov, Anatoly;
    • Luinenburg, Mark J.;
    • Romagnolo, Alessia;
    • Zimmer, Till S.;
    • van Scheppingen, Jackelien;
    • Bongaarts, Anika;
    • Broekaart, Diede W. M.;
    • Anink, Jasper J.;
    • Mijnsbergen, Caroline;
    • Jansen, Floor E.;
    • van Hecke, Wim;
    • Spliet, Wim G.;
    • van Rijen, Peter C.;
    • Feucht, Martha;
    • Hainfellner, Johannes A.;
    • Krsek, Pavel;
    • Zamecnik, Josef;
    • Crino, Peter B.;
    • Kotulska, Katarzyna;
    • Lagae, Lieven
    Publication type:
    Article
    34

    Down-regulation of the brain-specific cell-adhesion molecule contactin-3 in tuberous sclerosis complex during the early postnatal period.

    Published in:
    Journal of Neurodevelopmental Disorders, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s11689-022-09416-2
    By:
    • Korotkov, Anatoly;
    • Luinenburg, Mark J.;
    • Romagnolo, Alessia;
    • Zimmer, Till S.;
    • van Scheppingen, Jackelien;
    • Bongaarts, Anika;
    • Broekaart, Diede W. M.;
    • Anink, Jasper J.;
    • Mijnsbergen, Caroline;
    • Jansen, Floor E.;
    • van Hecke, Wim;
    • Spliet, Wim G.;
    • van Rijen, Peter C.;
    • Feucht, Martha;
    • Hainfellner, Johannes A.;
    • Krsek, Pavel;
    • Zamecnik, Josef;
    • Crino, Peter B.;
    • Kotulska, Katarzyna;
    • Lagae, Lieven
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44

    Long-term follow-up of a randomized controlled trial of choline for neurodevelopment in fetal alcohol spectrum disorder: corpus callosum white matter microstructure and neurocognitive outcomes.

    Published in:
    Journal of Neurodevelopmental Disorders, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s11689-022-09470-w
    By:
    • Gimbel, Blake A.;
    • Anthony, Mary E.;
    • Ernst, Abigail M.;
    • Roediger, Donovan J.;
    • de Water, Erik;
    • Eckerle, Judith K.;
    • Boys, Christopher J.;
    • Radke, Joshua P.;
    • Mueller, Bryon A.;
    • Fuglestad, Anita J.;
    • Zeisel, Steven H.;
    • Georgieff, Michael K.;
    • Wozniak, Jeffrey R.
    Publication type:
    Article
    45

    A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX).

    Published in:
    Journal of Neurodevelopmental Disorders, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s11689-022-09466-6
    By:
    • Berry-Kravis, Elizabeth;
    • Hagerman, Randi;
    • Budimirovic, Dejan;
    • Erickson, Craig;
    • Heussler, Helen;
    • Tartaglia, Nicole;
    • Cohen, Jonathan;
    • Tassone, Flora;
    • Dobbins, Thomas;
    • Merikle, Elizabeth;
    • Sebree, Terri;
    • Tich, Nancy;
    • Palumbo, Joseph M.;
    • O'Quinn, Stephen
    Publication type:
    Article
    46
    47
    48
    49
    50